DK0994884T3 - Diphosphonsyresalte til behandling af osteoporose - Google Patents
Diphosphonsyresalte til behandling af osteoporoseInfo
- Publication number
- DK0994884T3 DK0994884T3 DK98939625T DK98939625T DK0994884T3 DK 0994884 T3 DK0994884 T3 DK 0994884T3 DK 98939625 T DK98939625 T DK 98939625T DK 98939625 T DK98939625 T DK 98939625T DK 0994884 T3 DK0994884 T3 DK 0994884T3
- Authority
- DK
- Denmark
- Prior art keywords
- osteoporosis
- treatment
- acid salts
- diphosphonic acid
- substituted
- Prior art date
Links
- 208000001132 Osteoporosis Diseases 0.000 title abstract 3
- XQRLCLUYWUNEEH-UHFFFAOYSA-N diphosphonic acid Chemical class OP(=O)OP(O)=O XQRLCLUYWUNEEH-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- -1 aromatic amino alcohols Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/5765—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Dispersion Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001628A IT1293305B1 (it) | 1997-07-09 | 1997-07-09 | Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi |
| PCT/EP1998/004238 WO1999002539A1 (en) | 1997-07-09 | 1998-07-08 | Diphosphonic acid salts for the treatment of osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0994884T3 true DK0994884T3 (da) | 2004-02-16 |
Family
ID=11377528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98939625T DK0994884T3 (da) | 1997-07-09 | 1998-07-08 | Diphosphonsyresalte til behandling af osteoporose |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6410782B1 (da) |
| EP (1) | EP0994884B1 (da) |
| JP (1) | JP3681637B2 (da) |
| KR (1) | KR100396036B1 (da) |
| CN (1) | CN1161363C (da) |
| AT (1) | ATE251631T1 (da) |
| AU (1) | AU8806798A (da) |
| BR (1) | BR9810561A (da) |
| CA (1) | CA2303210A1 (da) |
| DE (1) | DE69818823T2 (da) |
| DK (1) | DK0994884T3 (da) |
| ES (1) | ES2207853T3 (da) |
| HU (1) | HUP0004679A3 (da) |
| IL (1) | IL133172A (da) |
| IT (1) | IT1293305B1 (da) |
| PT (1) | PT994884E (da) |
| WO (1) | WO1999002539A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100317935B1 (ko) * | 1999-10-20 | 2001-12-22 | 유승필 | 대사성 골질환 치료용 약제조성물 및 이의 제조방법 |
| EP1731150A4 (en) * | 2004-03-04 | 2010-06-16 | Makoto Yuasa | NIOSOM WITH A METAL-PORPHYRINE COMPLEX EMBEDDED THEREIN; PROCESS FOR ITS PREPARATION AND MEDICAMENT TO BE USED THEREFOR |
| US7645460B2 (en) | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of risedronate |
| US7645459B2 (en) | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of bisphosphonates |
| US20080286359A1 (en) | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
| US20080287400A1 (en) | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
| FR2926081B1 (fr) * | 2008-01-03 | 2010-02-19 | Univ Nantes | Derives d'acide hydroxy-bisphosphonique comme vecteur ciblant le tissu osseux |
| CN101977609B (zh) * | 2008-03-18 | 2012-11-14 | A·V·迪科夫斯基 | 用于具有不同病因学的骨组织吸收的预防和治疗的药物组合物 |
| KR20110079813A (ko) * | 2008-09-22 | 2011-07-08 | 아이시스 이노베이션 리미티드 | 이미다조〔1,2－α〕피리디닐 비스포스포네이트 |
| US8882740B2 (en) * | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
| CN105829921B (zh) * | 2013-12-19 | 2018-11-09 | 3M创新有限公司 | 包括包含带有磷表面处理剂的纳米粒子的自组装层的制品 |
| CN106361701B (zh) * | 2016-08-31 | 2019-08-27 | 上海交通大学 | 一种脂质体药物载体及其制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3751372A (en) | 1971-06-18 | 1973-08-07 | Hercules Inc | Scale and corrosion control in circulating water using polyphosphates and organophonic acids |
| GB1508772A (en) | 1975-04-04 | 1978-04-26 | Shell Int Research | Biologically active compositions |
| DD150744A1 (de) | 1980-04-02 | 1981-09-16 | Sigurd Wobst | Verfahren zur kontinuierlichen herstellung von cycloalkylhydroperoxiden |
| IT1201087B (it) | 1982-04-15 | 1989-01-27 | Gentili Ist Spa | Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche |
| DE3434667A1 (de) * | 1984-09-21 | 1986-04-03 | Henkel KGaA, 4000 Düsseldorf | 4-dimethylamino-1-hydroxybutan-1,1-diphosphonsaeure, deren wasserloesliche salze, verfahren zu ihrer herstellung sowie ihre verwendung |
| IT1187828B (it) * | 1985-05-24 | 1987-12-23 | Gentili Ist Spa | Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi |
| JPS63165457A (ja) | 1986-12-27 | 1988-07-08 | Lion Corp | 導電性樹脂組成物 |
| JPS63286478A (ja) | 1987-05-19 | 1988-11-24 | Lion Corp | 導電性塗料組成物 |
| DD273650A1 (de) | 1988-07-01 | 1989-11-22 | Robotron Elektronik | Verfahren zur chemischen anschlagvernicklung von kupferstrukturen auf dielektrika |
| ES2079673T3 (es) | 1990-07-13 | 1996-01-16 | Procter & Gamble | Composiciones anticalculo/antiplaca que utilizan azacicloalcano-difosfonatos. |
| EP0541037A3 (en) * | 1991-11-06 | 1997-02-26 | Takeda Chemical Industries Ltd | Squalene synthetase inhibitory composition and use thereof |
| CA2077312C (en) * | 1992-09-01 | 2000-02-08 | Ronald L. Oleka | Condensate polisher regenerant system |
| JPH06100576A (ja) * | 1992-09-21 | 1994-04-12 | Kirin Brewery Co Ltd | 骨粗鬆症治療剤または予防剤 |
| JP3238304B2 (ja) * | 1995-08-11 | 2001-12-10 | 三菱重工業株式会社 | スケール溶解液 |
| JP3445426B2 (ja) | 1995-12-26 | 2003-09-08 | 花王株式会社 | 高吸水性樹脂組成物 |
-
1997
- 1997-07-08 US US09/446,617 patent/US6410782B1/en not_active Expired - Fee Related
- 1997-07-09 IT IT97MI001628A patent/IT1293305B1/it active IP Right Grant
-
1998
- 1998-07-08 CN CNB988069326A patent/CN1161363C/zh not_active Expired - Fee Related
- 1998-07-08 DE DE69818823T patent/DE69818823T2/de not_active Expired - Fee Related
- 1998-07-08 BR BR9810561-2A patent/BR9810561A/pt not_active Application Discontinuation
- 1998-07-08 HU HU0004679A patent/HUP0004679A3/hu unknown
- 1998-07-08 PT PT98939625T patent/PT994884E/pt unknown
- 1998-07-08 CA CA002303210A patent/CA2303210A1/en not_active Abandoned
- 1998-07-08 EP EP98939625A patent/EP0994884B1/en not_active Expired - Lifetime
- 1998-07-08 AT AT98939625T patent/ATE251631T1/de not_active IP Right Cessation
- 1998-07-08 DK DK98939625T patent/DK0994884T3/da active
- 1998-07-08 ES ES98939625T patent/ES2207853T3/es not_active Expired - Lifetime
- 1998-07-08 JP JP2000502060A patent/JP3681637B2/ja not_active Expired - Fee Related
- 1998-07-08 WO PCT/EP1998/004238 patent/WO1999002539A1/en active IP Right Grant
- 1998-07-08 KR KR10-2000-7000135A patent/KR100396036B1/ko not_active IP Right Cessation
- 1998-07-08 IL IL13317298A patent/IL133172A/xx not_active IP Right Cessation
- 1998-07-08 AU AU88067/98A patent/AU8806798A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001509510A (ja) | 2001-07-24 |
| AU8806798A (en) | 1999-02-08 |
| CN1161363C (zh) | 2004-08-11 |
| CA2303210A1 (en) | 1999-01-21 |
| ITMI971628A1 (it) | 1999-01-09 |
| CN1261892A (zh) | 2000-08-02 |
| DE69818823T2 (de) | 2004-05-06 |
| IT1293305B1 (it) | 1999-02-16 |
| BR9810561A (pt) | 2000-08-15 |
| WO1999002539A1 (en) | 1999-01-21 |
| ITMI971628A0 (da) | 1997-07-09 |
| ES2207853T3 (es) | 2004-06-01 |
| ATE251631T1 (de) | 2003-10-15 |
| JP3681637B2 (ja) | 2005-08-10 |
| US6410782B1 (en) | 2002-06-25 |
| KR20010021577A (ko) | 2001-03-15 |
| HUP0004679A2 (hu) | 2001-08-28 |
| KR100396036B1 (ko) | 2003-08-27 |
| PT994884E (pt) | 2004-02-27 |
| DE69818823D1 (de) | 2003-11-13 |
| EP0994884B1 (en) | 2003-10-08 |
| HUP0004679A3 (en) | 2002-04-29 |
| EP0994884A1 (en) | 2000-04-26 |
| IL133172A0 (en) | 2001-03-19 |
| IL133172A (en) | 2005-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69830072D1 (de) | Radioaktive zusammensetzungen zur behandlung von prostatatumoren | |
| ATE150646T1 (de) | Behandlung von peridontalkrankheiten mit alendronat | |
| ATE284959T1 (de) | Unterbrechung der bindung der proteine mdm2 und p53 und entsprechende therapeutische anwendung | |
| NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| DK158541C (da) | Orale mopidamolformer og fremgangsmaade til deres fremstilling | |
| DE69942365D1 (de) | Gezielte zufuhr von pharmazeutischen agenzien zu verletzten geweben | |
| BR9811099A (pt) | Inibidores de urocinase | |
| DK0994884T3 (da) | Diphosphonsyresalte til behandling af osteoporose | |
| BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
| MX9304787A (es) | Prodrogas de acidos de imidazolcarboxilicos y composiciones farmaceuticasque las contienen. | |
| DE60043075D1 (de) | Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln | |
| ATE232874T1 (de) | Prostaglandin-konjugate zur behandlung von knochenkrankheiten | |
| ATE201597T1 (de) | Verabreichung von riluzol zur behandlung von neuro-aids | |
| ATE124681T1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| ATE291921T1 (de) | Verwendung von bisphosphonaten zur behandlung von osteogenese imperfecta | |
| ATE181240T1 (de) | Verwendung von somatostatinanalogen zur behandlung von melanomen | |
| HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
| NO990436L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
| ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| TR199801801T2 (xx) | Madde k�t�ye kullan�m�n�n tedavisi. | |
| NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
| DE3585312D1 (de) | Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden. | |
| ATE200865T1 (de) | Verwendung von phosphorderivaten von alkaloiden zur behandlung von endokrinopathien | |
| NO984190L (no) | FremgangsmÕte for behandling av insomnia |